Literature DB >> 21176105

Skin manifestations in autoinflammatory syndromes.

Markus Braun-Falco1, Thomas Ruzicka.   

Abstract

Autoinflammatory diseases encompass a group of inflammatory diseases that are non-infectious, non-allergic, non-autoimmune and non-immunodeficient. The term was initially coined for a small group of familial periodic fever syndromes of which familial Mediterranean fever (FMF) is the most common and best known. Genetic and molecular analyses demonstrated for the majority of these diseases an impairment of inflammasomes to cause an increased activity of an interleukin-1-dependent inflammatory response. Over the last years an increasing number of either rare hereditary syndromes or acquired common diseases could be summarized under the designation of autoinflammatory disease, thus creating an emerging new rubric of inflammatory diseases. Many of them display cutaneous manifestations as both concomitant or more rarely main symptoms. To name some of them like erysipelas-like erythema in FMF; urticaria-like rashes in tumor necrosis factor receptor 1- or cryopyrin-associated periodic syndromes (TRAPS, CAPS), hyperimmunoglobulin D syndrome (HIDS) or Schnitzler syndrome; pyoderma gangrenosum and acne in PAPA syndrome; or behçetoid aphthous ulcerations in HIDS and PFAPA syndrome. Based on the new insights into pathogenesis one increasingly realizes the good response of these diseases to IL-1 antagonist therapies.
© The Authors • Journal compilation © Blackwell Verlag GmbH, Berlin.

Entities:  

Mesh:

Year:  2010        PMID: 21176105     DOI: 10.1111/j.1610-0387.2010.07580.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  15 in total

1.  [CME article: "Autoinflammatory syndromes/fever syndromes"].

Authors:  M Meurer
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

Review 2.  SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.

Authors:  Davide Firinu; Vanessa Garcia-Larsen; Paolo Emilio Manconi; Stefano R Del Giacco
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 3.  [Pyoderma gangrenosum and Sweet's syndrome : Cutaneous manifestations of autoinflammatory disorders].

Authors:  B Meier; J-T Maul; L E French
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

Review 4.  Dermatologic Manifestations of Monogenic Autoinflammatory Diseases.

Authors:  Kyawt Win Shwin; Chyi-Chia Richard Lee; Raphaela Goldbach-Mansky
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

5.  [Fever attacks and urticarial exanthema during childhood].

Authors:  L Reinhold; B Homey; K Schatton
Journal:  Hautarzt       Date:  2021-04       Impact factor: 0.751

6.  Rituximab causing deep ulcerative suppurative vaginitis/pyoderma gangrenosum.

Authors:  Priya Selva-Nayagam; Gayle Fischer; Ian Hamann; Jack Sobel; Craig James
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

Review 7.  [Skin disorders in malignant hematologic diseases].

Authors:  M Schmid-Wendtner; T Hornung; M Meurer; C-M Wendtner
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

8.  [Severe acne in autoinflammatory diseases].

Authors:  S Faleri; K Feichtner; T Ruzicka
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

Review 9.  Febrile conditions in rheumatology.

Authors:  E Tóth; G Speer
Journal:  Clin Rheumatol       Date:  2012-08-26       Impact factor: 2.980

Review 10.  Pyoderma gangrenosum: pathogenetic oriented treatment approaches.

Authors:  Uwe Wollina; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2014-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.